Skip to main content

Gastrointestinal: SYMBIOTIC-03

Trial ID
 07222800
Trial Sponsor
Pfizer

Study Name: An Interventional, Phase 3, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of PF-08634404 in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Treatment-Naïve Participants with Metastatic Colorectal Cancer